Synopsis
Synopsis
0
USDMF
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
1. Capval
2. Capval Tropfen
3. Embonate, Noscapine Hydrogen
4. Hydrochloride, Noscapine
5. Hydrogen Embonate, Noscapine
6. Librochin Prikkelhoest
7. Narcotine
8. Noscapect
9. Noscapine
10. Noscapine Hydrochloride
11. Noscapine Hydrogen Embonate
12. Prikkelhoest, Librochin
13. Tropfen, Capval
14. Tuscalman
1. Noscapine Hydrochloride
2. 912-60-7
3. Narcotine Hydrochloride
4. Ttn62ith9i
5. Teletux
6. Tucotine
7. Stilco
8. Lyobex Retard
9. Difmetus Kapseln
10. Tussicure P
11. Germose Noscapine
12. Opian Hydrochloride
13. Vadebex Hydrochloride
14. Coscopin Hydrochloride
15. Nectadon Hydrochloride
16. Opianine Hydrochloride
17. Terbenol Hydrochloride
18. Coscotabs Hydrochloride
19. Narcosine Hydrochloride
20. Narcompren Hydrochloride
21. Narcotine, Hydrochloride
22. Unii-ttn62ith9i
23. Nsc 5366 Hydrochloride
24. Key-tusscapine Hydrochloride
25. Methoxyhydrastine Hydrochloride
26. Ccris 8985
27. 1-alpha-narcotine Hydrochloride
28. Noscapine Hydrochloride [jan:nf]
29. 1(3h)-isobenzofuranone, 6,7-dimethoxy-3-((5r)-5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, Hydrochloride, (3s)-
30. Einecs 213-014-9
31. Noscapinehydrochloride
32. 1(3h)isobenzofuranone, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, Hydrochloride, (s-(r*,s*))-
| Molecular Weight | 449.9 g/mol |
|---|---|
| Molecular Formula | C22H24ClNO7 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 4 |
| Exact Mass | 449.1241298 g/mol |
| Monoisotopic Mass | 449.1241298 g/mol |
| Topological Polar Surface Area | 76.9 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 647 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Antitussive Agents
Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally. (See all compounds classified as Antitussive Agents.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
72
PharmaCompass offers a list of Noscapine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Noscapine Hydrochloride manufacturer or Noscapine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Noscapine Hydrochloride manufacturer or Noscapine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Noscapine Hydrochloride API Price utilized in the formulation of products. Noscapine Hydrochloride API Price is not always fixed or binding as the Noscapine Hydrochloride Price is obtained through a variety of data sources. The Noscapine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A N0963 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of N0963, including repackagers and relabelers. The FDA regulates N0963 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. N0963 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of N0963 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A N0963 supplier is an individual or a company that provides N0963 active pharmaceutical ingredient (API) or N0963 finished formulations upon request. The N0963 suppliers may include N0963 API manufacturers, exporters, distributors and traders.
click here to find a list of N0963 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The N0963 Drug Master File in Japan (N0963 JDMF) empowers N0963 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the N0963 JDMF during the approval evaluation for pharmaceutical products. At the time of N0963 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of N0963 suppliers with JDMF on PharmaCompass.
A N0963 CEP of the European Pharmacopoeia monograph is often referred to as a N0963 Certificate of Suitability (COS). The purpose of a N0963 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of N0963 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of N0963 to their clients by showing that a N0963 CEP has been issued for it. The manufacturer submits a N0963 CEP (COS) as part of the market authorization procedure, and it takes on the role of a N0963 CEP holder for the record. Additionally, the data presented in the N0963 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the N0963 DMF.
A N0963 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. N0963 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of N0963 suppliers with CEP (COS) on PharmaCompass.
A N0963 written confirmation (N0963 WC) is an official document issued by a regulatory agency to a N0963 manufacturer, verifying that the manufacturing facility of a N0963 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting N0963 APIs or N0963 finished pharmaceutical products to another nation, regulatory agencies frequently require a N0963 WC (written confirmation) as part of the regulatory process.
click here to find a list of N0963 suppliers with Written Confirmation (WC) on PharmaCompass.
N0963 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of N0963 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right N0963 GMP manufacturer or N0963 GMP API supplier for your needs.
A N0963 CoA (Certificate of Analysis) is a formal document that attests to N0963's compliance with N0963 specifications and serves as a tool for batch-level quality control.
N0963 CoA mostly includes findings from lab analyses of a specific batch. For each N0963 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
N0963 may be tested according to a variety of international standards, such as European Pharmacopoeia (N0963 EP), N0963 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (N0963 USP).
